Proposal to purchase Poolbeg Pharma shares from distribution in specie shareholders
Open Orphan PLC (AIM:ORPH) Proposal to Distribution in Specie Shareholders
Open Orphan PLC (AIM:ORPH) Presentation at World Vaccine Congress
hVIVO presents on the outcomes from the world’s first COVID-19 characterisation study
Open Orphan PLC (AIM:ORPH) Characterisation Study results in Nature Medicine
COVID-19 Characterisation Study peer reviewed results published in industry leading periodical Nature Medicine
Open Orphan plc (AIM:ORPH) £5m RSV human challenge study contract win
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO, a
Open Orphan plc distribution in specie of Poolbeg Pharma plc shares – Q&A
Open Orphan distribution in specie shares and in particular some people had been concerned that they were unable to trade them.
Microsaic Systems (AIM:MSYS) Board Appointment and Strategic Update
Microsaic (AIM: MSYS) is pleased to announce the appointment of Robert Moore as an Independent Non-executive Director of the Company, with immediate effect.
Open Orphan PLC (AIM:ORPH) Trading Update and screening facilities expansion
Volunteer Recruitment and Laboratory Facilities Expansion
Open Orphan PLC (AIM: ORPH) Appointment of Chief Executive Officer
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces the
Open Orphan PLC (AIM: ORPH) FDA Breakthrough Designation for Big Pharma RSV
Vaccine candidate assessed in successful human challenge trial conducted by hVIVO
Open Orphan PLC (AIM: ORPH) Positive results from RSV Human Challenge Study
Data on Phase 2a study published in New England Journal of Medicine
Open Orphan plc (AIM: ORPH) Launch of STRiVE project
Respiratory viral strains suitable for challenge agents being collected from consenting volunteers
